Osteonecrosis associated with short-term oral administration of bisphosphonate

Journal of Prosthetic Dentistry

Volumn 101, Issue 5, 2009, Pages 289-292

  Takagi, Yuki ^a   Sumi, Yasunori ^a   Harada, Atsushi ^a  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BONE DENSITY CONSERVATION AGENT; DRUG DERIVATIVE; ETIDRONIC ACID; RISEDRONIC ACID;

AGED; ARTICLE; BONE NECROSIS; CASE REPORT; CHEMICALLY INDUCED DISORDER; DENTURE; FEMALE; HUMAN; JAW DISEASE; MANDIBLE; MOUTH ULCER; ORAL DRUG ADMINISTRATION; WOUND HEALING;

ADMINISTRATION, ORAL; AGED; BONE DENSITY CONSERVATION AGENTS; DENTURE, PARTIAL, REMOVABLE; ETIDRONIC ACID; FEMALE; HUMANS; MANDIBLE; MANDIBULAR DISEASES; ORAL ULCER; OSTEONECROSIS; WOUND HEALING;

EID: 65349159329     PISSN: 00223913     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3913(09)00049-3     Document Type: Article

References (18)

1. Chapurlat R.D., and Delmas P.D. Drug insight: Bisphosphonates for postmenopausal osteoporosis. Nat Clin Pract Endocrinol Metab 2 (2006) 211-219
2. Ruggiero S.L., Mehrotra B., Rosenberg T.J., and Engroff S.L. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62 (2004) 527-534
3. Migliorati C.A., Siegel M.A., and Elting L.S. Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment. Lancet Oncol 7 (2006) 508-513
4. Brooks J.K., Gilson A.J., Sindler A.J., Ashman S.G., Schwartz K.G., and Nikitakis N.G. Osteonecrosis of the jaws associated with use of risedronate: report of 2 new cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 (2007) 780-786
5. Migliorati C.A., Casiglia J., Epstein J., Jacobsen P.L., Siegel M.A., and Woo S.B. Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper. J Am Dent Assoc 136 (2005) 1658-1668
6. Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, and American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 65 (2007) 369-376
7. Marx R.E., Sawatari Y., Fortin M., and Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63 (2005) 1567-1575
8. Marx R.E. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61 (2003) 1115-1117
9. Wang J., Goodger N.M., and Pogrel M.A. Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg 61 (2003) 1104-1107
10. Woo S.B., Hellstein J.W., and Kalmar J.R. Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144 (2006) 753-761
11. Tanvetyanon T., and Stiff P.J. Management of the adverse effects associated with intravenous bisphosphonates. Ann Oncol 17 (2006) 897-907
12. Kuehn B.M. Reports of adverse events from bone drugs prompt caution. J Am Med Assoc 295 (2006) 2833-2836
13. Malden N.J., and Pai A.Y. Oral bisphosphonate associated osteonecrosis of the jaws: three case reports. Br Dent J 203 (2007) 93-97
14. American Dental Association Council on Scientific Affairs. Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations. J Am Dent Assoc 137 (2006) 1144-1150
15. Bamias A., Kastritis E., Bamia C., Moulopoulos L.A., Melakopous I., and Bozas G. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 23 (2005) 8580-8587
16. Chapurlat R.D., and Delmas P.D. Drug insight: Bisphosphonates for postmenopausal osteoporosis. Nat Clin Pract Endocrinol Metab 2 (2006) 211-219
17. Ruggiero S.L., Fantasia J., and Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 (2006) 433-441
18. Yarom N., Yahalom R., Shoshani Y., Hamed W., Regev E., and Elad S. Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome. Osteoporos Int 18 (2007) 1363-1370